These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 37532243
1. Is Methotrexate Ototoxic? Investigating the Ototoxic Late Effects of Pediatric Cancer Treatment. Moore B, Sheets G, Doss J, Umrigar A, Norman M, Fang Z, Prasad P, Musso A, Clay S, Tsien F. Am J Audiol; 2023 Sep 06; 32(3):657-664. PubMed ID: 37532243 [Abstract] [Full Text] [Related]
2. Platinum-induced hearing loss after treatment for childhood cancer. van As JW, van den Berg H, van Dalen EC. Cochrane Database Syst Rev; 2016 Aug 03; 2016(8):CD010181. PubMed ID: 27486906 [Abstract] [Full Text] [Related]
6. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis. Dillard LK, Lopez-Perez L, Martinez RX, Fullerton AM, Chadha S, McMahon CM. Cancer Epidemiol; 2022 Aug 03; 79():102203. PubMed ID: 35724557 [Abstract] [Full Text] [Related]
8. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec. Peleva E, Emami N, Alzahrani M, Bezdjian A, Gurberg J, Carret AS, Daniel SJ. Pediatr Blood Cancer; 2014 Nov 03; 61(11):2012-7. PubMed ID: 24976616 [Abstract] [Full Text] [Related]
9. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients. Waissbluth S, Del Valle Á, Chuang A, Becker A. Int J Pediatr Otorhinolaryngol; 2018 Aug 03; 111():174-179. PubMed ID: 29958605 [Abstract] [Full Text] [Related]
15. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma. Bass JK, Huang J, Onar-Thomas A, Chang KW, Bhagat SP, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Heath JA, McCowage G, Cohn RJ, Fisher MJ, Robinson G, Broniscer A, Gajjar A, Gurney JG. Pediatr Blood Cancer; 2014 Apr 03; 61(4):601-5. PubMed ID: 24504791 [Abstract] [Full Text] [Related]
17. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)]. Biró K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I. Magy Onkol; 2006 Apr 03; 50(4):329-35. PubMed ID: 17216007 [Abstract] [Full Text] [Related]
18. Audiologists' perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey. Konrad-Martin D, Polaski R, DeBacker JR, Theodoroff SM, Garinis A, Lacey C, Johansson K, Mannino R, Milnes T, Hungerford M, Clark KD. J Cancer Surviv; 2023 Feb 03; 17(1):69-81. PubMed ID: 36729345 [Abstract] [Full Text] [Related]
19. Ototoxicity monitoring in children treated with platinum chemotherapy. Brooks B, Knight K. Int J Audiol; 2018 Sep 03; 57(sup4):S34-S40. PubMed ID: 28737048 [Abstract] [Full Text] [Related]
20. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa. Paken J, Govender CD, Pillay M, Ayele BT, Sewram V. BMC Cancer; 2021 Jul 16; 21(1):822. PubMed ID: 34271863 [Abstract] [Full Text] [Related] Page: [Next] [New Search]